DNANexus to Use $15M Series C to Better Meet Research, Clinical Customers' Cloud Needs | GenomeWeb

DNANexus said recently that it has raised $15 million in a Series C financing round, and company officials told BioInform this week that the funds are earmarked for commercialization efforts and to scale up to better support global customers.

According to CEO Richard Daly, in 2013 the company "largely perfected the functionality that allows us to support customers' genomic data into the cloud" working in concert with large genomics centers, pharmaceutical companies, commercial test developers, and kit manufactures.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.